The tumour suppressor gene p53 is extensively studied for its importance in
cancer, In its active conformation, p53 is tetrameric and one domain - the
tetramerization domain - permits the oligomerization of this protein. Unti
l recently, little attention was given to this domain because, in contrast
to the DNA-binding domain, it is not often mutated in cancer, However, vari
ous experimental studies have shown evidence that the tetramerization domai
n is essential for DNA binding, protein-protein interactions, post-translat
ional modifications, and p53 degradation. Moreover, single mutations in the
tetramerization domain can inactivate the wild-type protein in a manner si
milar to that seen with mutations in the DNA-binding domain, Interestingly,
the phenotype of several tetramerization domain mutants differs from that
observed with DNA-binding domain mutants. In this review, current knowledge
about the importance of the tetramerization domain to the function of p53
will be summarized.